Buy, Sell or Hold: Theratechnologies Inc (TH-T) — Stock Predictions at Stockchase

skip to content

Home Daily Stock Opinions and Ratings Theratechnologies Inc (TH-T)

TSE:TH

2.15

0.12 (5.91%) 1d

Related posts

Most Anticipated Earnings: IAG-T, BDT-T and more Canadian Companies Reporting Earnings this Week (Nov 04-08)Yields and stocks climb, oil falls Most Anticipated Earnings: MRE-T, PSI-T and more Canadian Companies Reporting Earnings this Week (Aug 05-09).

WAIT

Best quarter is the last one, which ends in February. December - May is optimal holding period. Lately, it's been trending lower. No reason to be enticed just yet. Want to see support at major moving averages.

biotechnology / pharmaceutical

COMMENT

Biotechs can be very volatile. 2016 to early-2018 saw an uptrend, then turned down to the present. Be cautious now. TH-T is waiting for FDA approvals of its drugs which could swing this up sharply.

biotechnology / pharmaceutical

BUY

If this was a fundamental disaster, it's going to be news driven. If it's the only company in the sector that's falling, tech analysis goes out the window. It's at a pocket after a big pullback. It's a gamble, but it's probably at a point to buy right now.

biotechnology / pharmaceutical

PARTIAL BUY

Every biotech company always has some life-altering technology, and it's always way too positive. Small-mid caps like this can have big moves. Reversing a sideways trend, and breaking up to new levels, so that's positive. Maybe some movement up to $12. Take a small position, don't expose yourself too much. Support will be around $8.50, and if it breaks, start exiting.

biotechnology / pharmaceutical

RISKY

Had a sharp run, then a sharp pullback. Technically it looks good here. You could buy it here. But he doesn't know this company well.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick July 10/17 - Down 13%.) He knew it was high risk. The biggest risk would be a non-approval or delay on the process of getting a drug approved. A delay came to place. Still watch the story for the future.

biotechnology / pharmaceutical

TOP PICK

They are taking the profits and cash flow from their drug to introduce a second drug, expected next year. (Analysts’ target: $9.50).

biotechnology / pharmaceutical

BUY

Canadian. Excellent phase 3 product results. A take over target, in a position of being sold right now. They have lots of cash. At this level it’s a dollar below financing. Good product. Would buy at this price.

biotechnology / pharmaceutical

BUY

Excellent phase 3 results. They are a takeover target, they have lots of cash. Annoyed at management because last month they had 61 million in cash, and decided to put the company up for sale, while at the same time decided to raise money. They can't have it both ways. Nothing wrong with the product. Good one to hold and to buy. Should be stable.

biotechnology / pharmaceutical

BUY

Had 2 good phase 3 trials. 2nd trial is going on right now. Long-term data was very effective. FDA approval will probably happen in the next year. Probably the best takeout candidate in a biotechnology space.

biotechnology / pharmaceutical

STRONG BUY

Bought today. Have had great results on their phase 3. They've done their financing, they've got their cash. Go to market probably in 2010, 2011. Likely will be acquired. Mixed view of what the drug could be worth.

biotechnology / pharmaceutical

DON'T BUY

Think you are arriving at the party late on this one. He would have preferred to buy on the breakout pattern in late 2006.

biotechnology / pharmaceutical

BUY

Phase 3 shoed their drug did not have side effects. This resulted in a large move in the stock price. Now doing a financing, which will be a net positive for the stock. Could be a takeout or could be a partnership.

biotechnology / pharmaceutical

WEAK BUY

Management team's not bad. A very, very cheap stock. Have a good balance sheet. Thinks you can make money by buying it here regardless of what happens. Would prefer a larger market cap company.

biotechnology / pharmaceutical

BUY

Very bullish on this stock. Has a lot of cash. A good price.

biotechnology / pharmaceutical

Showing 1 to 15 of 16 entries

«
‹
1
2
›
»

Next Page

Theratechnologies Inc(TH-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Theratechnologies Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Theratechnologies Inc(TH-T) Frequently Asked Questions

What is Theratechnologies Inc stock symbol?

Theratechnologies Inc is a Canadian stock, trading under the symbol TH-T on the Toronto Stock Exchange (TH-CT). It is usually referred to as TSX:TH or TH-T

Is Theratechnologies Inc a buy or a sell?

In the last year, there was no coverage of Theratechnologies Inc published on Stockchase.

Is Theratechnologies Inc a good investment or a top pick?

Theratechnologies Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Theratechnologies Inc.

Why is Theratechnologies Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Theratechnologies Inc worth watching?

0 stock analysts on Stockchase covered Theratechnologies Inc In the last year. It is a trending stock that is worth watching.

What is Theratechnologies Inc stock price?

On 2024-12-13, Theratechnologies Inc (TH-T) stock closed at a price of $2.15.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

© Stockchase Inc.